Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

Similar articles for PubMed (Select 19451638)

1.

Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment.

Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, Duffy PE.

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9027-32. doi: 10.1073/pnas.0901415106. Epub 2009 May 18.

2.

Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study.

Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ.

Clin Infect Dis. 2012 Jul;55(1):42-50. doi: 10.1093/cid/cis301. Epub 2012 Mar 22.

3.

Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya.

Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden Eng J, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP.

Malar J. 2012 Jul 4;11:134. doi: 10.1186/1475-2875-11-134.

4.

Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.

Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M, Deloron P.

Malar J. 2011 Jul 19;10:196. doi: 10.1186/1475-2875-10-196.

5.

Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania.

Malisa A, Pearce R, Abdullah S, Mutayoba B, Mshinda H, Kachur P, Bloland P, Roper C.

Afr Health Sci. 2011 Jun;11(2):142-50.

6.

Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancy.

Hommerich L, von Oertzen C, Bedu-Addo G, Holmberg V, Acquah PA, Eggelte TA, Bienzle U, Mockenhaupt FP.

Malar J. 2007 Nov 8;6:144.

7.

Increased prevalence of dhfr and dhps mutants at delivery in Malawian pregnant women receiving intermittent preventive treatment for malaria.

Lin JT, Mbewe B, Taylor SM, Luntamo M, Meshnick SR, Ashorn P.

Trop Med Int Health. 2013 Feb;18(2):175-8. doi: 10.1111/tmi.12028. Epub 2012 Nov 30.

8.

Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance.

Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE.

Clin Infect Dis. 2011 Aug 1;53(3):224-30. doi: 10.1093/cid/cir376.

9.
10.

High prevalence of sulfadoxine/pyrimethamine-resistant alleles of Plasmodium falciparum isolates in pregnant women at the time of introduction of intermittent preventive treatment with sulfadoxine/pyrimethamine in Gabon.

Bouyou-Akotet MK, Mawili-Mboumba DP, Tchantchou Tde D, Kombila M.

J Antimicrob Chemother. 2010 Mar;65(3):438-41. doi: 10.1093/jac/dkp467. Epub 2010 Jan 6.

11.

HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment.

Menéndez C, Serra-Casas E, Scahill MD, Sanz S, Nhabomba A, Bardají A, Sigauque B, Cisteró P, Mandomando I, Dobaño C, Alonso PL, Mayor A.

Clin Infect Dis. 2011 Jan 1;52(1):41-8. doi: 10.1093/cid/ciq049.

12.

Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.

Filler SJ, Kazembe P, Thigpen M, Macheso A, Parise ME, Newman RD, Steketee RW, Hamel M.

J Infect Dis. 2006 Aug 1;194(3):286-93. Epub 2006 Jun 20.

13.
14.

Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.

Tinto H, Ouédraogo JB, Zongo I, van Overmeir C, van Marck E, Guiguemdé TR, D'Alessandro U.

Am J Trop Med Hyg. 2007 Apr;76(4):608-13.

15.

Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.

Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, Bienzle U.

J Infect Dis. 2008 Nov 15;198(10):1545-9. doi: 10.1086/592455.

16.

Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.

Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ.

J Infect Dis. 2008 Jun 1;197(11):1605-13. doi: 10.1086/587645.

17.

High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.

Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T.

Acta Trop. 2003 Mar;85(3):363-73.

PMID:
12659974
18.

High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin.

Moussiliou A, De Tove YS, Doritchamou J, Luty AJ, Massougbodji A, Alifrangis M, Deloron P, Ndam NT.

Malar J. 2013 Jun 10;12:195. doi: 10.1186/1475-2875-12-195.

19.

Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.

Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW.

Lancet Infect Dis. 2012 Dec;12(12):942-9. doi: 10.1016/S1473-3099(12)70222-0. Epub 2012 Sep 18. Review.

PMID:
22995852
20.

Low-dose treatment with sulfadoxine-pyrimethamine combinations selects for drug-resistant Plasmodium falciparum strains.

Kun JF, Lehman LG, Lell B, Schmidt-Ott R, Kremsner PG.

Antimicrob Agents Chemother. 1999 Sep;43(9):2205-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk